play

Effective, easy to use, economic

308 EXCIMER SYSTEM: The Advantages

The 308 EXCIMER SYSTEM has several decisive benefits: its intense monochromatic UVB light is highly effective for the targeted treatment of psoriasis and vitiligo. The handheld system is small, mobile and has an easy to use design. And its low acquisition, operating and service costs make the system very cost-effective.

Clinically proven effectiveness

  • intense, monochromatic UVB therapy with the optimal wavelength of 308 nm
  • as effective as an excimer laser
  • lesion targeting of localized lesions for safe and fast treatments
  • spot size up to 16 cm² for quicker treatments even of large areas
  • variable dose thanks to power densities between 50 and 6,000 mJ/cm²

High patient acceptance

  • pain-free treatment, no downtime
  • visible results after only a few sessions
  • maximum protection of healthy skin through lesion targeting
  • supersedes time-consuming radiation of the whole body

Easy to use

  • handy, compact and mobile system
  • big, easy-to-use color touch screen
  • intuitive menu, treatments can be delegated
  • integrated automatic MED (Minimum Erythema Dose) test for convenient and time-saving identification of the individual treatment dose

Very cost-effective

  • low acquisition and operating costs, maintenance-free technology
  • no consumables, no gas needed
  • only handheld excimer system worldwide: transportable and compact
  • carrying case allows flexible transport and use at different locations

Product comparison

All systems at a glance: Our product comparison gives you a quick overview of our laser and light-based systems and their applications.

Show product comparison

 

Our Products

Statements

Moshe Lapidoth M.D., MPH

"...much more convenient and giving me the same clinical results."  read more

Dr. B. S. Chandrashekar

"... cheers, confident smiles and excitement ... at unbelievable low costs."  read more

Prof. Dr. Ulrich Amon

"...response time... absolutely equal to the excimer laser."  read more

Login